ctrl K

/

Search

Popular

KO Coca Cola Company Stock

TSLA Tesla Inc Stock

AMD Advanced Micro Devices Stock

SPY SPDR S&P 500 ETF Trust ETF

NVDA Nvidia Stock

Price Alert

MIRA Pharmaceuticals Inc. (MIRA)

NASDAQ: MIRA · Real-Time Price · USD

1.51

0.04 (2.72%)

At close: Aug 15, 2025, 3:59 PM

Insider Trading

Transcripts

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

MIRA News

6 days ago - MIRA Pharmaceuticals' Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabalin - accessnewswire.com
19 days ago - MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study - accessnewswire.com
20 days ago - MIRA Pharmaceuticals Announces FDA Clearance of IND for Ketamir-2, Enabling U.S. Clinical Trials in Neuropathic Pain - accessnewswire.com
38 days ago - MIRA Reports Clear Reversal of Anxiety-Related Behavior in Animal Model Using SKNY-1, an Oral Drug Candidate for Obesity and Nicotine Addiction Under Definitive Agreement for Acquisition - accessnewswire.com
46 days ago - MIRA Reports Potent Inflammatory Pain Relief from Non-Psychoactive Marijuana Analog Mira-55 in Animal Model, Matching Morphine Without Opioid Risks - accessnewswire.com
49 days ago - MIRA Reports Up to 30% Weight Loss and Reversal of High-Calorie and Nicotine Cravings in an Animal Model of Obesity and Craving Using SKNY-1, a Drug Candidate Under Definitive Agreement for Acquisition - accessnewswire.com
54 days ago - MIRA Pharmaceuticals Announces New Data Underscoring Potential of SKNY-1 - A Drug Candidate Pending Acquisition - To Disrupt Weight Loss and Smoking Cessation Markets Without CNS Side Effects - accessnewswire.com
61 days ago - MIRA Pharmaceuticals' Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology - accessnewswire.com
74 days ago - Visionstate Launches MIRA to Digitize Facility Inspections and Expand SaaS Platform - thenewswire.com
82 days ago - MIRA Pharmaceuticals to Participate in BIO 2025 in Boston and Highlights Ongoing Progress Across Clinical Program - accessnewswire.com

Add to Watchlist

✕

Stocknear

All-in-one Stock Analysis Platform to research your trading ideas.

Sections

Stocks
IPOs
ETFs
Blog

Services

Pricing Plan
Get Support
Learning Center
Advertise

Website

Login
FAQ
Sitemap

Company

About
Contact Us
Terms of Use
Privacy Policy
Data Disclaimer
Imprint

© 2025 Stocknear. All rights reserved.